Zynx Health Launches Zynx OncologyCare, Providing Evidence-Based Chemotherapy Order Sets Developed with the National Comprehensive Cancer Network

LOS ANGELES--(Business Wire)--
Zynx Health, the leader in evidence-based healthcare, announces the official
launch of Zynx OncologyCare, which offers a comprehensive library of actionable
order sets developed through a collaboration with the National Comprehensive
Cancer Network (NCCN). The order sets are based on the NCCN Chemotherapy Order
Templates and are consistent with the NCCN Clinical Practice Guidelines in
Oncology and the NCCN Drugs & Biologics Compendium.

"We are thrilled to announce the release of Zynx OncologyCare, a product that
we`ve developed in collaboration with NCCN," said Victor Lee, MD, director of
content development at Zynx Health. "We believe that Zynx OncologyCare
chemotherapy order sets will enable oncology practices to streamline order entry
workflow and optimize reimbursement potential." Zynx OncologyCare order sets are
based on the NCCN Drugs & Biologics Compendium, which several major payers
regard as a primary source for making cancer coverage determinations. By relying
on Zynx OncologyCare order sets, clients can be confident about reimbursement.

Zynx OncologyCare directly addresses the complexities of appropriate
chemotherapy administration, including:

* Chemotherapy dosing
* Supportive care, such as premedications and antiemetic therapy
* Monitoring and hold parameters, with applicable laboratory orders
* Safety parameters and special instructions

Clients can access the order sets using Zynx`s Web-based software, AuthorSpace.
AuthorSpace streamlines the content management process by enabling clients to
access, customize, share, and update order sets. Cancer centers can then deploy
the order sets at the point of care, either in paper form or on an intranet, or
to an electronic medical record (EMR) system.

"The NCCN Chemotherapy Order Templates, which are the basis for Zynx
OncologyCare, can enhance patient safety by helping clinicians standardize
patient care, reduce medication errors, and anticipate and manage adverse
events," said William T. McGivney, PhD, chief executive officer of NCCN. "NCCN
is pleased to collaborate with Zynx Health on this new product that promotes the
safe use of drugs and biologics in cancer care."

About Zynx Health

Zynx Health was founded in 1996 by thought leaders in evidence-based healthcare
and healthcare quality improvement. Acquired by Hearst Corporation in 2004, Zynx
has grown to become a recognized leader in evidence-based clinical decision
support and offers a suite of online solutions that help clinicians treat their
patients based on the best available evidence from systematic research. The Zynx
team of physicians, nurses, and allied health professionals rigorously reviews
the latest peer-reviewed literature to develop clinically relevant summaries and
distill evidence-based best practices.

Zynx`s evidence-based solutions guide the care of more than 50% of patients who
are discharged from US hospitals. More than 1,700 hospitals nationwide trust
Zynx evidence-based decision support to address regulatory initiatives, optimize
pay-for-performance reimbursement, and measurably improve the quality, safety,
and efficiency of patient care. For more information about Zynx Health, visit
www.zynxhealth.com or call 888.333.ZYNX (9969).

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of
21 of the world`s leading cancer centers, is dedicated to improving the quality
and effectiveness of care provided to patients with cancer. Through the
leadership and expertise of clinical professionals at NCCN Member Institutions,
NCCN develops resources that present valuable information to the numerous
stakeholders in the healthcare delivery system. As the arbiter of high-quality
cancer care, NCCN promotes the importance of continuous quality improvement and
recognizes the significance of creating clinical practice guidelines appropriate
for use by patients, clinicians, and other healthcare decision-makers. The
primary goal of all NCCN initiatives is to improve the quality, effectiveness,
and efficiency of oncology practice so patients can live better lives.

Zynx Health Contact:
Derek Baird
Director of Business Affairs
310.954.5686
dbaird@zynx.com

Copyright Business Wire 2009